- ICH GCP
- USA klinikai vizsgálatok nyilvántartása
- Klinikai vizsgálat NCT03299465
Yoga for Fatigue in the Survivors of Bone Marrow Transplantation
Yoga for Persistent Fatigue in the Survivors of Bone Marrow Transplantation: A Feasibility Study
A tanulmány áttekintése
Részletes leírás
OBJECTIVES
Primary Objective: To assess the feasibility of an organized yoga intervention for HCT survivors with CRF.
Hypothesis: A trial of yoga in the HCT survivor population will be deemed feasible if at least 75% of study subjects demonstrated protocol adherence rate of at least 80%.
Secondary Objectives:
- Explore participants' perceptions regarding yoga and physical activity
Hypothesis: HCT survivors will be positive about yoga and will express satisfaction with the yoga program, as will be shown during focus groups that will be held at the end of the yoga program.
- Evaluate the association between yoga practice and self-efficacy and self-regulation
Hypothesis: Adherence to yoga will be associated with higher self-efficacy and selfregulation scores.
- Evaluate the changes in CRF scores from baseline to the end of the yoga program.
Hypothesis: CRF scores at the end of the yoga program will be lower than CRF scores at baseline.
- Evaluate whether changes in CRF are associated with changes in depression, sleep disturbances, physical activity, and pain.
Hypothesis 5: Improvement in CRF will be associated with increased physical activity and decreased depression, sleep disturbances, and pain.
- Evaluate the safety of yoga practice in HCT survivors.
Hypothesis: Yoga will be considered as a safe intervention for CRF in HCT survivors as demonstrated by the absence of adverse events or serious adverse events related to or associated with yoga practice.
Tanulmány típusa
Beiratkozás (Tényleges)
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi helyek
-
-
Michigan
-
Ann Arbor, Michigan, Egyesült Államok, 48105
- Cancer center
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- Adult HCT survivors as defined by being at least 100 days post autologous or allogeneic transplantation for a malignant disease. There is no restriction to enrollment by donor type, donor cell source, presence or absence of graft versus host disease.
- Age ≥ 18 years at the time of transplant.
- A history of persistent CRF as defined by a perception of general CRF for at least one month before enrollment.
- A history of at least moderate CRF as defined by a CRF score of 4 or more on a 10-point Visual Analog Scale.
- Participants who are deemed qualified for yoga movements according to the Yoga Qualifying Movements Screening Checklist (a checklist developed by researchers at the University of California, Los Angeles to promote yoga safety through assessing the eligibility of each patient)
Exclusion Criteria:
- A self-reported current practice of yoga or any other mind-body therapy, including but not limited to meditation or hypnosis therapy in the past 30 days prior to study enrollment.
- Subjects currently on supplemental oxygen support.
- Subjects currently receiving hemodialysis.
- Subjects currently admitted to an inpatient unit at Michigan Medicine.
- Subjects with an uncontrolled, active infection. Subjects with viremia (Cytomegalovirus or other) may be enrolled, provided they are on active therapy and at the discretion of the treating physician.
- Subjects who have relapsed after their autologous or allogeneic transplant.
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Egyéb
- Kiosztás: N/A
- Beavatkozó modell: Egyetlen csoportos hozzárendelés
- Maszkolás: Nincs (Open Label)
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
---|---|
Kísérleti: Yoga arm
A six-week restorative yoga intervention consisting of a weekly, 60-minute yoga group class led by a certified yoga instructor along with twice-weekly home practice using yoga DVD.
|
This is a single arm study and all participants will be assigned to a six-week restorative yoga intervention.
Restorative yoga sessions will consist of gentle physical poses (asanas), breathing control (pranayama), and relaxation (savasana).
|
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
---|---|---|
Practice log
Időkeret: Weekly during the six-week intervention period
|
Yoga practice at home will be documented on a log sheet to be filled out by participants at the end of each practice week.
We will check class attendance during the weekly telephone call with the study participants.
We will use a log sheet to document in-class yoga practice and location of the yoga performance.
At the end of the program, the number of yoga practice hours per participant will be tabulated.
This number will be used to evaluate participants' adherence to yoga practice.
|
Weekly during the six-week intervention period
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
---|---|---|
Side-effects/adverse events log
Időkeret: Weekly during the six-week intervention period
|
All subjects will be asked to complete a Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) weekly.
The PRO-CTCAE questionnaire in this study includes a total of six items (numbness and tingling, dizziness, blurry vision, muscle pain, joint pain, others).
|
Weekly during the six-week intervention period
|
Multidimensional Fatigue Symptom Inventory
Időkeret: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The Multidimensional Fatigue Symptom Inventory-Short Form (MFSISF) will be used to measure fatigue in the past seven days.
The MFSISF includes a total of 30 items that produce five subscales: general fatigue, physical fatigue, emotional fatigue, mental fatigue, and vigor.
All items have a possible score of 0 to 4, 0 representing "not at all" and 4 being "extremely".
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
PROMIS-SF-Fatigue
Időkeret: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The PROMIS-SF-Fatigue will be used to measure fatigue in the past seven days.
The PROMIS-SF-fatigue is a unidimensional scale that measures general fatigue.
It contains eight items with a possible score of 1 to 5 for each item.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
Brief Pain Inventory - Short Form
Időkeret: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The Brief Pain Inventory - Short Form (BPISF) will be used to measure pain in the past 24 hours.
The BPISF is a 9-item questionnaire used to evaluate the severity of a participants' pain and the impact of pain on the patient's daily functioning.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
PROMIS-SF-depression
Időkeret: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The PROMIS-SF-depression will be used to measure depression in the past seven days.
The PROMIS-SF-depression contains eight items with a possible score of 1 to 5 for each item (1: never, 5: always).
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
PROMIS-SF-sleep disturbance
Időkeret: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The PROMIS-SF-sleep disturbance will be used to measure sleep disturbance in the past seven days.
The PROMIS-SF-sleep disturbance contains eight items with a possible score of 1 to 5 for each item.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
Index of Self-Regulation Scale
Időkeret: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The Index of Self-Regulation Scale (ISR) is designed to measure individuals' level of self-regulation for health behaviors.
The ISR contains nine items that produces three subscales: reconditioning, stimulus control, and behavioral monitoring.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
Self-Efficacy for Managing Chronic Disease Scale
Időkeret: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
Self-efficacy will be measured using the Self-Efficacy for Managing Chronic Disease Scale (SEMCD).
The SEMCD contains six items.
Each item has a possible score of 1 to 10 (1: not at all confident, 10: totally confident).
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
PROMIS-SF- physical function
Időkeret: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The PROMIS-SF- physical function contains 12 items with a possible score of 1 to 5 for each item (1: unable to do, 5: without any difficulty).
All items are reversely coded.
The total score can range from 12 to 60 with higher scores indicating better physical function.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
electronic pedometer
Időkeret: At baseline (before treatment) and within 10 days of the last in-class yoga session
|
The electronic pedometer is an objective measure of physical activity.
It is a simple, unobtrusive device that can be placed on the belt or waistband to count the number of steps taken.
|
At baseline (before treatment) and within 10 days of the last in-class yoga session
|
Együttműködők és nyomozók
Szponzor
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
Elsődleges befejezés (Tényleges)
A tanulmány befejezése (Tényleges)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
További vonatkozó MeSH feltételek
Egyéb vizsgálati azonosító számok
- HUM00130548
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .
Klinikai vizsgálatok a Rák
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)ToborzásAnatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8 | Korai stádiumú emlőkarcinóma | Anatómiai Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8Egyesült Államok
-
University of Southern CaliforniaNational Cancer Institute (NCI)ToborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8 | Invazív emlőkarcinómaEgyesült Államok
-
National Cancer Institute (NCI)Aktív, nem toborzóRosszindulatú szilárd daganat | Anatómiai Stage III Breast Cancer AJCC v8 | Anatómiai Stage IV Breast Cancer AJCC v8 | Invazív emlőkarcinóma | Mell adenokarcinómaEgyesült Államok
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)ToborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8Egyesült Államok
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institute on Aging (NIA)ToborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8Egyesült Államok
-
Mayo ClinicNational Cancer Institute (NCI)ToborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8Egyesült Államok
-
City of Hope Medical CenterNational Cancer Institute (NCI)ToborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8 | HER2-negatív emlőkarcinómaEgyesült Államok
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)ToborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8Egyesült Államok
-
Fred Hutchinson Cancer CenterMég nincs toborzásAnatómiai stádiumú emlőrák AJCC v8 | Anatómiai Stage II Breast Cancer AJCC v8 | Anatómiai Stage III Breast Cancer AJCC v8Egyesült Államok
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)BefejezveVékonybél adenokarcinóma | III. stádiumú vékonybél-adenokarcinóma AJCC v8 | IIIA stádiumú vékonybél adenokarcinóma AJCC v8 | IIIB stádiumú vékonybél adenokarcinóma AJCC v8 | IV. stádiumú vékonybél adenokarcinóma AJCC v8 | Vater adenokarcinóma ampulla | Stage III Ampull of Vater Cancer AJCC v8 | Stage... és egyéb feltételekEgyesült Államok